FDA Approves First Non-Opioid Pain Reliever: Journavx by Vertex Pharmaceuticals
By
ortegaygasset
Hot, fresh, and worth queueing round the block for.
Summary
The FDA approved Vertex Pharmaceuticals's Journavx (suzetrigine) in January 2025, marking the first non-opioid pain reliever.
Key quotes
· 4 pulledBut post-operative pain relief has continued to rely on opioids, derivatives of opium, the addictive substance employed since ancient times.
Although no other drug has managed to match the rapid, potent, and broadly effective relief delivered by opioids.
This all changed in January 2025, when the FDA approved Vertex Pharmaceuticals’s Journavx (suzetrigine): the first non-opioid pain reliever.
leaving researchers keen to find a better solution.
You might also wanna read
Genomic test trial suggests hormone therapy alone may be sufficient for low-risk breast cancer patients
A groundbreaking genomic test trial suggests that breast cancer patients with low test scores could be treated with hormone therapy alone, a
apple.news·3h ago
Study finds bird masturbation is natural behavior, not caused by captivity stress
A study on masturbation among birds, particularly parrots, finds that the behavior is natural and more common in the wild than in captivity.
theguardian.com·3h ago
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·3h ago
Lab-grown sperm from stem cells could help infertile men, but may require gene editing
A US start-up called Paterna Biosciences claims it can take stem cells from men's testes and grow them into sperm cells in the lab, potentia
newscientist.com·4h ago
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
biotechniques.com·4h ago
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
bit.ly·5h ago